High Tech Research in Portugal | GenomeWeb

Portugal has debuted a new cancer and neuroscience research center in Lisbon, reports the Associated Press. The facility was built by the Champalimaud Foundation, which began work four years ago. Portuguese businessman Antonio Champalimaud gave the foundation $688 million to complete the work and make the facility one of the best in the world, AP says. The foundation is now looking to recruit researchers from all over the world to work in the new center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.